Success Stories: A Scientist’s Trust in Our Team Leads to NIW Approval In 76 Days With Assistance of Premium Processing
Client’s Testimonial:
“This is great and exciting news. Thank you very much for all your efforts and professionalism with my case.”
On January 14th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Scientist I in the Field of Genomic Epidemiology (Approval Notice).
General Field:Genomic Epidemiology
Position at the Time of Case Filing: Scientist I
Country of Origin: Nigeria
State of Residence at the Time of Filing: California
Approval Notice Date: January 14th, 2025
Processing Time: 2 months, 15 days (Premium Processing Requested)
Case Summary:
A Nigerian expert in genomic epidemiology approached us seeking assistance with his NIW (National Interest Waiver) application.
As part of our standard practice, we ensured that he was fully informed about his options, the process ahead, and the adjudication procedures. This allowed him to make an informed decision and sign the retainer agreement, enabling us to commence case preparation. Our team meticulously gathered the required documents and information to craft a compelling petition for him.
We discovered that he holds an M.S. in molecular biology and genomics and has been conducting research as a proficient fellow at a prestigious institution. His work has led to 26 peer-reviewed journal articles (3 first-authored and 3 co-first-authored) and 1 book chapter. These contributions have garnered 885 citations and have been published in no fewer than 11 highly ranked peer-reviewed journals, showing a remarkably strong record for a researcher in genomic epidemiology.
His proposed endeavor focuses on developing genomic and bioinformatic techniques to analyze and understand the spread of pathogens, thereby improving the tracking and containment of infectious disease outbreaks.
The national importance of his research is evident, as it has been funded by esteemed organizations, including the National Institutes of Health, the U.S. Centers for Disease Control and Prevention, the Biomedical Advanced Research and Development Authority, and the Bill & Melinda Gates Foundation. These organizations reserve funding for research that advances national interests, including health improvement, disease prevention, economic well-being, poverty alleviation, and large-scale social impact.
All these factors helped us establish that his research is of exceptional importance. It bridges gaps in global health disparities, promotes scientific inclusivity, and offers practical applications that extend far beyond traditional research boundaries. His work addresses some of the most urgent challenges in global health and poverty reduction, making significant strides in these areas.
We also gathered 4 recommendation letters from experts in the field who attested to the relevance and impact of his work. One of these experts highlighted:
“Considering [client’s] exceptional skill set in genomic epidemiology with specializations in pathogen surveillance and bioinformatics, his proficiency in computational and statistical analysis stands as a cornerstone in advancing our understanding of disease transmission dynamics. His unique expertise, coupled with a commitment to making information publicly available, establishes him as a key player in the realm of infectious disease research, particularly during critical events like the COVID-19 pandemic.”
As a result, the adjudication process was streamlined due to our team’s thorough preparation, leading to our client’s approval in just 2 months and 15 days with the assistance of Premium Processing. We are pleased to have had the opportunity to work with him and extend our best wishes for his future endeavors.